Effects of Stem Cell in Corneal Limbus on Corneal Epithelial Wound Healing

Clinical Analysis on 25 Cases of Corneal Limbus Tumors

角膜缘肿瘤25例临床分析

Local anesthesia was performed with 25G syringe needle through pars plana or corneal limbus infusion and super limbus incisions to eliminate silicone oil.

用25G针头插入平坦部或角膜缘穿刺作灌注，同时由角膜缘穿刺取硅油。

Methods Compared the effect of homologous conjunctiva and corneal limbus transplantation and drug treatment.

方法对异体结膜联合角膜缘部移植组和常规药物治疗组的疗效进行回顾性分析。

Vitrectomy led by ocular endoscope on the treatment of endophthalmitis with severe corneal opacity

眼内窥镜引导玻璃体手术治疗伴有严重角膜混浊的眼内炎

24% of the eyes were slight corneal opacity ( 12 eyes);

角膜云翳12眼，占24%；

Surgery for corneal opacity associated with cataract

角膜混浊合并白内障的手术治疗研究

Corneal opacity is one of the important post-mortem changes.

角膜混浊是一种重要的死后变化。

Conclusions Risk diseases include corneal ulcer, adherent leucoma of cornea, simple leucoma of cornea developed from herpes simplex keratitis or chemical burn.

结论高危病种有角膜溃疡、粘连性角膜白斑、单疱病毒性角膜炎及化学伤导致的单纯性角膜白斑。

Visible ulcer or opacity of cornea.

眼角膜可见溃疡或混浊。

Combined use of triazoles for fungal ulcer of the cornea

联合应用三唑类药物治疗真菌性角膜溃疡的效果

Sixteen eyes of 16 cases of Mooren ulcer of cornea were treated with circular cut and scorching and followed up for 6 months to 3 years, the curative ratio was 81.3%.

用割烙术治疗蚕蚀性角膜溃疡16例16只眼，随访6个月～2年，治愈率达81.3%。

Infectious serpent ulcer of cornea

感染匐行性角膜溃疡

A study on the mechanism of the curing of Mooren ulcer of cornea through circular cutting and scorching

割烙术治疗蚕蚀性角膜溃疡疗效机理的研究

Observation on the treatment of Mooren ulcer of cornea with circular cut and scorching

割烙术为主治疗蚕蚀性角膜溃疡临床观察

The utility model belongs to an ophthalmology emersion technique sphere, specifically relates to a non-penetration integral artificial cornea for artificial organs.

本实用新型属于眼科复明技术领域，具体涉及一种人工器官非穿透一体式人工角膜。

Doctors said that there haven't been any adverse effects and the artificial cornea was mimicking a natural one with patients producing tears.

医生还说，人造角膜不仅没有副作用，并且还能仿照天然角膜制造泪水。

Construction of tissue engineered actively artificial cornea with acellular cornea matrix combined with bone morrow-derived mesenchymal stem cells

脱细胞角膜基质与骨髓间充质干细胞复合构建组织工程化活性人工角膜

Reconstruction of tissue engineered artificial cornea in vitro is an efficient way to solve the shortage of corneal transplantation materials.

体外重建组织工程化人工角膜是解决角膜移植材料匾乏的一条有效途径。

Better materials and designs are on the way and the true artificial cornea will be developed soon.

随着人工角膜材料、设计的进步，未来可能有真正意义上的人工角膜供临床使用。

Artificial cornea and stem cells transplant are developing and usefull technique, but there is a long way to go.

人们现正对人工角膜和干细胞移植的技术进行研究，而且两种技术也在不断的发展当中，并且将会成为有效的方法，但这还需时日。